The present study evaluated the involvement of glucose transport and phosphorylation in glucose-stimulated insulin release from pancreatic islets. Using quantitative histochemical techniques, we investigated basal islet glucose content, islet glucose uptake in situ during acute extreme experimental hyperglycemia, and islet glucokinase activity in several animal models of diabetes and obesity. The basal islet glucose content in anaesthetized diabetic or obese rodents was either the same or higher than that in their relevant controls. The rate of glucose uptake of islet tissue in these animals after an i.v. glucose injection was different. The db+/db+ mouse and the obese Zucker rat exhibited significantly reduced islet glucose uptake rates. RIP-cHras transgenic mice, BHE/cdb rats and partially pancreatectomized rats showed normal islet glucose uptake rates. The activity of islet glucokinase was increased to a different degree related to the blood glucose level. All five animal models of diabetes or obesity exhibited either a delay or a reduction of insulin release in response to supra maximal glucose stimulation. Our results indicate that the impairment of glucose-induced insulin release in diabetes is not consistently associated with a reduction of islet glucose uptake nor a change of glucokinase activity. (J. Clin. Invest. 1994. 93:2473-2481.) Key words: diabetic animal -glucokinase * GLUT2 * insulin releasepancreatic islet Introduction Under physiological conditions, pancreatic (3 cells sense the change ofblood glucose level and adjust insulin output accordingly. The mechanism ofglucose sensing by (3 cells is, however, still unclear. There are two candidates for glucose sensors in pancreatic islets: the glucose transporter (GLUT2)' and gluco-
Introduction
Under physiological conditions, pancreatic (3 cells sense the change ofblood glucose level and adjust insulin output accordingly. The mechanism ofglucose sensing by (3 cells is, however, still unclear. There are two candidates for glucose sensors in pancreatic islets: the glucose transporter (GLUT2)' and gluco- 1 . Abbreviations used in this paper: GLUT2, glucose transporter-2;PX, pancreatectomy; RIP-cHras, transgene composed of human [Val'2] Hras oncoprotein regulated by the rat insulin promoter.
kinase. GLUT2 is part of the ,3 cell plasma membrane ( 1, 2) and transports glucose into : cells in a facilitative manner with a Km of 15-20 mM (3, 4) . Evidence favoring a role of GLUT2 in glucose sensing is substantial: (a) In the obese, diabetic Zucker rat, GLUT2 expression is reduced at the mRNA and protein levels. The function of GLUT2 in islets is impaired. These defects correlate with insufficient insulin secretion in response to glucose (5) . (b) An IgG preparation from patients with newly diagnosed insulin-dependent diabetes mellitus reduced the glucose uptake and decreased glucose-induced insulin release of normal rat islets (6, 7) . GLUT2 has therefore been suggested as an essential element of the glucose sensor, and it has been proposed that a defect of GLUT-2 may play a crucial role in the pathogenesis of both insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus (8) . Glucokinase, on the other hand, is the pacemaker of the glucose metabolism in islets (9, 10) . The expression of glucokinase in the islet is controlled by a (3 cell specific promoter ( 11) , and its enzymatic activity is regulated by the blood glucose ( 12, 13) . Recently > 20 mutations ofthe glucokinase gene have been found in patients of mature onset diabetes of the young, who have impaired insulin secretion in response to glucose ( 14) . Kinetic studies of recombinant mutant human glucokinase indicated a reduction of enzyme activity and an increase of the glucose Km in many of the affected individuals ( 15 ) . These findings demonstrate that glucokinase is a crucial determinant of glucose metabolism in pancreatic islets and support the view that this enzyme may serve as a glucose sensor (16) .
The function of the islet glucose transporter and of glucokinase has been intensively studied using dispersed pancreatic (3 cells or isolated islets. However, the procedure of islet isolation by collagenase digestion of the pancreas may influence islet function and could compromise the outcome ofsuch studies, in particular the function of the glucose transporter, which is located in the ( cell membrane. In addition, one is unable to determine in these islets the basal glucose content, which is a reflection of the glucose transporter function in situ. To evaluate further the involvement ofglucose transport and phosphorylation in the glucose-sensing mechanism, it is desirable to study basal islet glucose content, islet glucose uptake in situ during hyperglycemia, and to determine glucokinase activity by optimal techniques in normal and diabetic animals.
The quantitative histochemical techniques as developed by 0. H. Lowry have been used since the 1950s ( 17) . These techniques permit the precise quantitation of enzymes, metabolites, and cofactors in microscopic structures sampled such that the in situ condition is virtually preserved. In its current version, which employs an oil well technique to handle volumes as small as 0.05 ul and the method of enzymatic cycling, femto-mol amounts of metabolites and cofactors, and picogram quantities ofenzymes can be determined accurately. The application of the methodology has already benefited the study of glucose metabolism in pancreatic islets (9, 18, 19) .
We therefore used quantitative histochemical methods to investigate these aspects ofglucose metabolism in islet samples dissected from freeze-dried cryostat sections ofpancreas and to study glucose-induced insulin release in rodents. Both normal and five different models of diabetes or obesity were used. Our results indicate that the impairment ofglucose-induced insulin release in these diabetic or obese animals is not consistently associated with a reduction of islet glucose uptake nor with a change in glucokinase activity. Defects in late steps ofislet glucose metabolism, metabolic coupling or insulin secretion per se must be considered as possible causes for the desensitization of (3 Animal surgery and sample preparation. Animals (except PX rats) were fasted overnight before the experiment. Nembutal (100 mg/kg body weight) was injected i.p. to anaesthetize the animal. The jugular vein was cannulated for glucose and inulin injection, and the carotid artery was cannulated for the rapid collection ofblood. After cannulation, heparin ( 100 USP U/kg body weight) was injected. Inulin (0.5 g/kg body weight), an extracellular marker, was injected 10 min before the glucose bolus. Glucose (0.85 g/kg body weight) was then injected within 5 s. Animals were killed at 0, 30, or 60 s after glucose injection, and blood as well as pancreatic tissue samples were collected. The plasma was kept at -20°C for inulin, glucose and insulin determinations. The pancreas was quickly frozen in Freon-12 cooled to -1 50°C by liquid nitrogen and stored at -80°C for measuring inulin, glucose and insulin content in islet, as well as islet glucokinase. Sprague-Dawley rats, BHE rats (fed a high fat diet) and Zucker rats (lean andfa/fa) were also used for an i.v. glucose tolerance test. Glucose (0.85 g/kg body weight) was injected into the jugular vein within 5 s. Blood was collected in 0.3 ml samples at 0, 1, 2, 5, 10, 15, 30, 60, 90, and 120 min after glucose injection and plasma samples were kept at -20°C until assayed for glucose and insulin.
Determination of plasma inulin, glucose and insulin concentrations. The inulin and glucose concentrations in the plasma were measured with an NADP coupled fluorometric assay (20) . Plasma insulin was determined by radioimmunoassay as described before (21 Sections of the pancreas were cut 20 Mm thick at -20'C in a cryostat, freeze dried overnight at -350C, and then stored under vacuum at -20'C. Islets were dissected from pancreatic sections with the aid of a stereo microscope at low magnification. The weights of the specimens were obtained with the quartz fiber fishpole balance (23) .
Determination of islet insulin, glucose, and inulin contents. The islet insulin content was determined by radioimmunoassay. The glucose and inulin content in the pancreatic islet tissue were measured by a fluorometric oil well method combined with enzymatic cycling of NADP ( 18, 20) . For islet glucose content determination, islet samples were first suspended in 0.1 Mul of 0.015 N HCl under mineral oil and incubated at 60C for 10 min. The glucose in the sample was measured enzymatically with hexokinase and glucose-6-phosphate dehydrogenase and followed by a 500-fold amplification by enzyme cycling. For the inulin determination, the islet sample was suspended in 0.05 Ml of 0.1 N NaOH and heated at 105'C for 25 min, then 0.1 l of 0.1 N HCI was added followed by heating at 105'C for 25 min. Fructose, resulting from hydrolysis of inulin, was determined fluorometrically with an NADP-dependent assay using hexokinase, phosphoglucose isomerase and glucose-6-phosphate dehydrogenase followed by a 3,000-fold amplification through enzyme cycling in order to achieve higher sensitivity. Standard curves of NADPH (4-20 pmol), glucose (4-20 pmol) , and inulin (20-100 fmol) were used in each experiment for calculation. Samples from nine individual islets were assayed and averaged for each animal. The islet glucose and inulin contents were then used to calculate the islet total glucose space, extracellular space and intracellular glucose space using the following formulas: Islet glucokinase determination. Glucokinase activity in islet tissue was determined using a radiometric micromethod (24 
Results
Basal plasma glucose, basal insulin level, and glucose-induced insulin release. Animals were fasted overnight, except for the PX and sham-PX rats, and plasma glucose as well as basal insulin levels under anesthesia were determined in five rodent models of diabetes or obesity and their controls (Table I and Fig. 1 (Fig. 1 ). The plasma glucose remained at an excessively high level of > 30 mM for 120 min after the glucose bolus, while in the controls plasma glucose returned to basal level. The first phase of glucose-induced insulin release in BHE/cdb rats (on a high fat diet) and obese Zucker rats reached higher hormone levels than in their controls (P < 0.05), but the second phase response was similar in experimental groups and controls. Basal glucose content and in situ glucose uptake of islet tissue after glucose i.v. injection. Quantitative histochemical techniques were used to determine the basal islet glucose content and to assess the capacity of islet cell glucose transport at near-maximal substrate load. The result for each animal represents the average of nine different islet samples. The standard errors were < 10% for glucose determinations and < 20% for inulin determinations.
The total basal islet glucose contents in normal animals ranged from 27 to 35 mmol/kg dry tissue (Tables II and III) . These values extrapolated to a total islet glucose space of 2.7 to 3.9 liter/kg dry tissue. The values of total islet glucose space indicate that the glucose concentration in islet tissue is equal to the plasma glucose concentration. This calculation is based on an islet water space of 0.75 liter/kg wet islet tissue (26) . In different animal models of diabetes or obesity, basal total islet glucose contents were higher than in controls, except in the case of RIP-cHras transgenic mice. The values of total glucose space in all the animal models of diabetes or obesity ranged from 2.4 to 3.6 liter/kg dry tissue, which was very similar to results in their relevant control groups. The values for islet extracellular spaces ranged from 0.55 to 0.92 liter/kg dry weight in the control groups and from 0.55 to 0.85 liter/kg dry weight in most diabetic and obese animals, except in the BHE/ cdb rat which manifested a much higher extracellular space. The intracellular glucose space of islets in the controls ranged from 2.1 to 3.3 liter/kg dry weight. In the RIP-cHras transgenic mouse, PX and obese Zucker rats, the intracellular glucose space ranged from 1.9 to 2.8 liter/kg dry weight, not significantly lower than the values in their controls. However, the intracellular glucose space in the db+/db+ mice and in the BHE/cdb rat was clearly lower than that of their controls. The Plasma glucose and insulin samples were collected from individual animals killed at 0, 30, and 60 s. * P < 0.05, compared with 0 time point in the same group; * P < 0.01 compared with 0 time point in the same group. § n = 8; 11n = 3. ' P < 0.05 compared with control group; ** P < 0.01 compared with control group at 0 time point (both for glucose and insulin data). $ The atypical high plasma glucose was the result of an inadvertently large i.v. glucose load (compare with lean Zucker rats). After glucose injection, the total islet glucose content in all animals was increased significantly at 30 s. In control animals, the total islet glucose space was reduced to -75% ofthat under the basal condition, indicating that equalization ofintracellular and extracellular glucose had not been complete. The intracellular and extracellular glucose were approximately equalized at 60 s after glucose injection in the control group, except in the C57BL/KsJ mice in which the intracellular glucose space reached 79% of that in the basal condition. In diabetic or obese animals, apparent glucose uptake rates varied widely. In the db+/db+ mice, glucose uptake was much slower than that in the control. Even after 60 s, the intracellular glucose space was Pancreatic samples were collected at 0 time to determine the basal islet total glucose content, extracellular and intracellular space. * P < 0.05, compared with basal condition in the same group; t P < 0.01 compared with basal condition in the same group. I P < 0.05 compared with control group at basal condition. 11 The strikingly high total glucose contents and the expanded extracellular space values after glucose loading were a manipulation of an inadvertently high dose of i.v. glucose (also Table I ).
still < 50% of that at the basal condition, indicating that the glucose uptake rate of these islet cells was much slower than that in controls. In the obese Zucker rat, the glucose uptake rate was also decreased, yet 60 s after glucose injection, the intracellular glucose space had reached 74% of that at the basal condition. However, in RIP-cHras mice, BHE/cdb rats (fed either a stock or a high fat diet) and PX rats, equalization between extracellular and intracellular glucose concentrations in the islets was nearly achieved at 60 s.
Glucokinase activity and insulin content in pancreatic islets. The islet glucokinase activity in the db+/db+ mice, the BHE/ cdb rat (fed either a stock or a high fat diet) and the obese Zucker rat, as well as their control groups was measured with a radiometric oil well method. The supernatant of rat liver homogenate was used as a biological standard. The V.. value of liver glucokinase was 60.97±3.28 mol/kg DNA per h and the glucose Km was 13.10±1.98 mM, comparable to results previously obtained in this laboratory (24) . The glucose Km of islet glucokinase in all the animals ranged from 8 to 19 mM (Table  IV) . The V. of glucokinase in control animals ranged from 103 to 142 mmol/kg dry tissue per h, which is equivalent to 5.15 to 7.10 mol/kg DNA per h using a factor of 20 ng DNA/ tig dry islet tissue (27) . These values are similar to previous results obtained with a fluorometric method in rat islet isolated by a collagenase procedure ( 13, 28) . Since the , cell mass may be reduced in these diabetic animals as indicated by the reduced intracellular glucose space, the glucokinase V.,, was also expressed on the basis of intracellular glucose space. On that basis, islet glucokinase activities were substantially increased. The the obese Zucker rat needs to be intensively studied to clarify whether this increased glucose Km has pathological significance for the impairment of glucose-induced insulin release in these animals.
The insulin contents in BHE/cdb rats and in obese Zucker rats were comparable to control values, while the insulin content in the db+/db+ mice was only 5-10% of that in the control.
Relationship ofin situ islet glucose uptake and glucose-induced insulin release. The relationship of in situ islet glucose uptake and glucose induced insulin release was explored in diabetic or obese animals and their controls (Fig. 3) . The intracellular glucose space and glucose-induced insulin release at 30 and 60 s after glucose injection were expressed in relative terms as compared to the relevant values at the basal condition (defined as 100). The control barin this figure reflects the mean of five different control groups. In control animals, the plasma insulin levels increased 2.5 fold at 30 s after glucose injection, and almost fourfold at 60 s. However, in diabetic and obese animals, the glucose-induced insulin release was delayed or greatly reduced compared with that of their controls. Glucose uptake was impaired only in db+/db+ mice and obese Zucker rats. Thus there was no absolute association between glucose uptake and glucose-induced insulin release.
Discussion
The relationship of islet in situ glucose uptake, glucokinase activity, and glucose-induced insulin release was investigated in five animal models of diabetes or obesity using quantitative histochemical methods. The unique potential of the present approach and the implications of present results for our understanding of the pathogenic process leading to diabetes mellitus in these animals are discussed.
Advantages and limitations of quantitative histochemistry for the study ofpancreatic islet glucose metabolism
The pancreatic islet glucose transporter and glucokinase have emerged as important topics in studying the pathogenesis of diabetes. A direct assessment of the involvement of islet glucose transport and glucokinase in rodent models of diabetes and obesity with quantitative histochemical methods, which allows in situ measurements, appeared therefore highly desirable. The rapid freezing method for tissue sampling and the free-hand dissection of pure pancreatic islet specimens from freeze-dried tissue sections, as employed here, avoid artifacts that could be introduced by the lengthy procedure of collagenase isolation of pancreatic islets, which usually precedes most physiological or biochemical investigation. Thus, the quantitative histochemical method offers an independent reexamination of the issue. The determination of the total islet glucose space, ofthe inulin or extracellular space and ofthe intracellular glucose space under basal condition and after a maximal Figure 3 . Summary of the relationship of islet in situ glucose uptake and glucose-induced insulin release in five animal models of diabetes or obesity and their relevant controls. Data are expressed in terms of relative changes of glucose uptake and insulin release at 30 and 60 s compared to the corresponding values at basal conditions. The control panels show the mean value of the relative changes in all four groups of control animals at 30 and 60 s compared to the corresponding value at basal condition. For actual individual values both in control groups and in diabetic or obese rodents, please see Tables I-III. *P < 0.05, **P < 0.01 compared with the corresponding values at basal condition. ND, not determined.
glucose load provides essential information not obtainable by other methodology. The determination of glucokinase activity by a quantitative radiometric oil well method applied here provides a measure of(3 cell glucose metabolism, since this enzyme is an important determinant of glucose metabolism.
This approach provides unambiguous results when applied to normal islet tissue. The finding of an intracellular glucose space of2-3 liter/kg dry tissue both under basal conditions and 60 s after a maximal glucose load in C57BL/KsJ control and RIP-cHras mice, normal Sprague-Dawley rats, BHE rats at 50 d of age, sham-PX and PX rats, as well as lean and obese Zucker rats (Tables II and III) documents clearly (a) that plasma glucose and (3-cell intracellular glucose are virtually equal under basal conditions, and (b) that the capacity for glucose transport is very high and almost certainly not rate limiting for islet glucose metabolism.
However, the interpretation of the results from some of these diabetic animals is less straightforward. The difficulties arise from the pathological alterations ofthe microscopic structure of pancreatic islets, most importantly of the increased fibrosis or the loss of cells that characterizes some of those models (i.e., the BHE/cdb rat and the db+/db+ mouse). It is known that db+/db+ mice have a reduced (-cell mass at 18 wk of age (29, 30 slower than in controls and could account for the delay ofglucose-stimulated insulin release. In addition, the depletion of insulin stored in the islets almost certainly contributes to the lack of rapid response to glucose challenge. However, the basal intracellular glucose level of 13 cells was probably supranormal as a result ofhyperglycemia and could explain high glucokinase activity and elevated plasma insulin. The data indicate that under basal conditions, glucose usage is very high in 13 cells of these diabetic mice.
(b) The RIP-cHras transgenic mouse expresses the H-ras gene under control of the rat insulin promoter and develops male 13 cell degeneration and diabetes in males. Hyperglycemia appears around 5 mo ofage (35) . The RIP-cHras mice we used here were 8-9 wk ofage. At this young age, the animals are still normoglycemic but the GLUT-2 in the islet was estimated to be reduced by about 90% (36) . Our results also showed that the plasma glucose and insulin levels were still in the normal range. The basal intracellular glucose space was comparable to that of C57BL/KsJ mice, and the islet glucose uptake rate was not significantly slower than that in the control. However, no increased insulin secretion was found up to 3 min after glucose challenge (data not shown). In addition, these mice did not show any high levels of fasting plasma insulin. It has been observed that when the pancreas from these transgenic mice were perfused with 6.6 mM glucose, a high baseline ofinsulin release was observed; insulin release stimulated by 16.7 mM glucose was even more pronounced than that in controls (35) . The reason for this difference remains unclear. It might be due to the different experimental design, since pancreatic perfusion might eliminate the influence of hormones and other factors which could modify insulin release in situ (37) (38) (39) .
(c) The BHE/cdb rat is a model for NIDDM without obesity. Previous studies have shown that these rats are characterized by an age related rise in serum lipids and a deterioration of glucose tolerance despite the rise in serum insulin levels in response to a glucose challenge (40, 41 ) . When these animals are fed a high fat and sucrose diet, the diabetic syndrome becomes more severe (42) . Here we showed that the fasting plasma glucose and insulin levels in these rats fed a high fat diet were significantly higher than those in the Sprague-Dawley rats, and that the i.v. glucose tolerance in these animals exhibited an abnormal blood glucose profile associated with a relatively high insulin release. The present study showed that BHE/cdb rats at 50 d of age had a normal islet intracellular glucose space, while the older BHE/cdb rats (fed either a stock diet or a high fat diet) had a reduced islet intracellular glucose space, which might be due to fibrotic changes. The islet glucose uptake rate appeared to be normal, and glucokinase seemed to be enhanced in these two groups of older BHE rats. This impaired insulin secretion in response to glucose is thus probably not due to reduced 13 cell glucose metabolism.
(d) The partially pancreatectomized rat becomes moderately diabetic following surgery that removes 90% of the pancreas, and is characterized by hyperglycemia, hypoinsulinemia and a blunted or absent insulin release response after glucose challenge (22). However, the islet intracellular glucose space and the glucose uptake rate after glucose injection were not different from those in sham-PX rats suggesting that glucose usage is normal.
(e) The obese Zucker rats who inherit obesity as an autosomal recessive trait are obese and hyperinsulinemic, but are relatively normoglycemic or show only slightly elevated blood sugar (43) . We found in our group of obese Zucker rats that glucose uptake rates were reduced and that the insulin release response to glucose stimulation was diminished or absent. The glucokinase activity in these animals was marginally increased to 140%, probably due to the mild hyperglycemia. The reduced glucose uptake rate could account for the delayed insulin release after glucose stimulation.
Relationship of islet in situ glucose uptake, glucokinase activity and glucose-induced insulin release Under basal conditions, the intracellular islet glucose space in five models of diabetes or obesity was either indistinguishable from controls or reduced. Even though in the db+/db+ mice the intracellular glucose space was reduced, there was probably ample glucose in the islet tissue to fuel the metabolism under steady-state conditions. In fact, the data suggest that intra-and extracellular glucose concentrations are equal under basal conditions. The hypoinsulinemia in the PX rat can therefore not be attributed to insufficient glucose supply to 13 cells. Similarly in the RIP-cHras transgenic mice, the reported reduction of 13 cell GLUT2 to 10% ofcontrols did not limit glucose access to 13 cells nor basal insulin release. Glucose transport can thus be discounted as the determining factor of glucose metabolism and insulin release under basal steady-state conditions. Glucose transport could, however, become rate limiting in transition states on a minute-to-minute time scale. In the db+/db+ mice, the glucose uptake rate was significantly decreased at 60 s after a glucose load. Obese Zucker rats also exhibited a decrease ofthe glucose uptake rate, but the intracellular glucose reached nearly 75% of that at basal conditions 1 min after a glucose load. The functional transport defect is thus relatively small. The RIP-cHras mice (even though drastically compromised by a lack of GLUT2 [36] ), BHE/cdb rats and PX rats showed normal glucose uptake rates. Glucose-induced insulin release in all five experimental groups was delayed or reduced. Impaired insulin release was therefore not correlated with impaired glucose uptake in these animals. However, it remains to be explored whether islet glucose in situ uptake is altered at time points of < 30 s, or when the blood glucose level increases submaximally. The present data show that a connection between reduced glucose uptake and abnormal acute insulin release might exist only in the db+/db+ mouse and obese Zucker rat.
Islet glucokinase activities in db+/db+ mice, BHE rats (with or without a high fat diet) and obese Zucker rats were higher than in their relevant controls suggesting that glucokinase was induced by the elevated blood glucose and the correspondingly increased islet glucose. Previously we have observed that in normal rats, the activity of islet glucokinase was regulated by the ambient glucose concentration both in situ and organ culture ( 12, 13) . The present results demonstrated 1-cell glucokinase induction might also occur in diabetic and obese animals. A glucokinase defect can therefore be excluded as cause of diabetes in these animals.
In summary, our present study further elucidates the relationship of islet glucose uptake and glucose-induced insulin release in five animal models ofdiabetes or obesity. A dysfunction ofGLUT-2 is ofminor or no consequence for intracellular glucose availability under basal equilibrium conditions and is not the universal cause of impaired insulin release in these animals. A defect of islet glucokinase is also excluded as cause of the pathology in db+/db+ mice, in BHE rats and in obese Zucker rats. The cause of the 13 cell's inability to respond to glucose stimulation might be located at later steps of glucose metabolism, in the metabolic coupling processes that connect glucose metabolism to secretion, or in the secretion mechanism itself.
